These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 25731697)

  • 21. Darzi review. Quality incentive puts 1bn pounds sterling at stake.
    Gainsbury S
    Health Serv J; 2008 Jul; ():6. PubMed ID: 18705116
    [No Abstract]   [Full Text] [Related]  

  • 22. Swings and roundabouts.
    Squire J
    Health Serv J; 2000 Mar; 110(5698):30-1. PubMed ID: 11183707
    [No Abstract]   [Full Text] [Related]  

  • 23. Paying for performance in the United States and abroad.
    Epstein AM
    N Engl J Med; 2006 Jul; 355(4):406-8. PubMed ID: 16870921
    [No Abstract]   [Full Text] [Related]  

  • 24. The quality and outcomes framework: triumph of technical rationality, challenge for individual care?
    Gillam S; Siriwardena AN
    Qual Prim Care; 2010; 18(2):81-3. PubMed ID: 20529468
    [No Abstract]   [Full Text] [Related]  

  • 25. Payment by results. How to steer clear of PbR gaming.
    Carlisle D
    Health Serv J; 2006 Mar; 116(5995):22-3. PubMed ID: 16583868
    [No Abstract]   [Full Text] [Related]  

  • 26. Quality of primary care in England with the introduction of pay for performance.
    Campbell S; Reeves D; Kontopantelis E; Middleton E; Sibbald B; Roland M
    N Engl J Med; 2007 Jul; 357(2):181-90. PubMed ID: 17625132
    [No Abstract]   [Full Text] [Related]  

  • 27. [Payment for performance had no effect on mortality. English reimbursement system in primary care did not live up to expectations].
    Borgquist L; Maun A
    Lakartidningen; 2015 May; 112():. PubMed ID: 26010846
    [No Abstract]   [Full Text] [Related]  

  • 28. Cash and care: a question of priorities.
    Trenchard H
    Nurs Focus; 1980 May; 1(9):347-52. PubMed ID: 6900954
    [No Abstract]   [Full Text] [Related]  

  • 29. Successes and failures of pay for performance in the United Kingdom.
    Roland M; Campbell S
    N Engl J Med; 2014 May; 370(20):1944-9. PubMed ID: 24827040
    [No Abstract]   [Full Text] [Related]  

  • 30. Lessons from major initiatives to improve primary care in the United Kingdom.
    Doran T; Roland M
    Health Aff (Millwood); 2010 May; 29(5):1023-9. PubMed ID: 20439901
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beyond pay for performance--emerging models of provider-payment reform.
    Rosenthal MB
    N Engl J Med; 2008 Sep; 359(12):1197-200. PubMed ID: 18799554
    [No Abstract]   [Full Text] [Related]  

  • 32. On the front lines of care: primary care doctors' office systems, experiences, and views in seven countries.
    Schoen C; Osborn R; Huynh PT; Doty M; Peugh J; Zapert K
    Health Aff (Millwood); 2006; 25(6):w555-71. PubMed ID: 17102164
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heaven can wait.
    Holland WW; Fitzgerald AP; Hildrey SJ; Phillips SJ
    J Public Health Med; 1994 Sep; 16(3):321-30. PubMed ID: 7999386
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quality and Outcomes Framework: smoke and mirrors?
    Ashworth M; Kordowicz M
    Qual Prim Care; 2010; 18(2):127-31. PubMed ID: 20529474
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Can pay for performance improve the quality of primary care?
    Roland M; Olesen F
    BMJ; 2016 Aug; 354():i4058. PubMed ID: 27492822
    [No Abstract]   [Full Text] [Related]  

  • 36. Incentive payments may reduce time for clinical care.
    Rickenbach M
    BMJ; 2001 Dec; 323(7325):1369-70. PubMed ID: 11739230
    [No Abstract]   [Full Text] [Related]  

  • 37. Putting the quality back into QIPP.
    Plumridge N
    Health Serv J; 2012 Sep; 122(6319):22-3. PubMed ID: 23074877
    [No Abstract]   [Full Text] [Related]  

  • 38. Access to cancer drugs: local autonomy or local tyranny?
    Dillon A
    Br J Hosp Med (Lond); 2008 Sep; 69(9):537; author reply 537. PubMed ID: 18822467
    [No Abstract]   [Full Text] [Related]  

  • 39. Access to cancer drugs: local autonomy or local tyranny?
    Sikora K
    Br J Hosp Med (Lond); 2008 Sep; 69(9):537; author reply 537. PubMed ID: 18819312
    [No Abstract]   [Full Text] [Related]  

  • 40. DoH under pressure to tackle perverse finance incentives.
    Harding ML
    Health Serv J; 2005 Jan; 115(5937):6. PubMed ID: 15658840
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.